$1.50
-0.11-6.83%
Últ. Act.: Oct 26, 5:42 PM
Aptevo Therapeutics (APVO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-6.16 | $-5.60 | $-8.09 | $-37.62 |
| Actual | $-5.31 | $-6.41 | $-6.23 | $-40.14 |
| Surprise | +13.8% | -14.5% | +23.0% | -6.70% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-3.58 | $-2.77 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-5.31 | $-6.16 | 13.8 % |
| Q1 | May 13, 2026 | $-6.41 | $-5.60 | -14.5 % |
| Q4 | Mar 26, 2026 | $-6.23 | $-8.09 | 23.0 % |
| Q3 | Nov 6, 2025 | $-40.14 | $-37.62 | -6.70 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 11, 2022 | $0 | $3.42M | -100.0 % |
| Q1 | May 12, 2022 | $3.11M | $3.75M | -17.0 % |
| Q4 | Mar 24, 2022 | $3.67M | $3.40M | 7.79 % |
| Q3 | Nov 12, 2021 | $3.10M | $3.65M | -15.2 % |